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ABSTRACT
Background and Objectives: Methicillin resistant Staphylococcus aureus (MRSA) is a major nosocomial pathogen causing 
significant morbidity and mortality. The aim of this study was to evaluate in vitro activities of different antibiotics against 
methicillin resistant Staphylococcus aureus. 
Materials and Method: The study was conducted over a period of one year (January 2009 – December 2009) in the Department 
of Microbiology, Army Medical College, the National University of Sciences and Technology, Pakistan. One hundred and 
thirty-nine Methicillin resistant Staphylococcus aureus isolated from the clinical specimens at Rawalpindi Military Hospital 
were subjected to in vitro susceptibility against various antimicrobials using Kirby Bauer disc diffusion technique.
Results: All the isolated MRSA organisms were uniformly susceptible to vancomycin, linezolid and tigecycline. Other drugs 
which were found to be effective were chloramphenicol, and rifampacin. Most of the MRSA were isolated from pus samples.
Conclusion: .Vancomycin, tigecycline and linezolid were effective against methicillin resistant strains of S.aureus. This study 
suggests that chloramphenicol and rifampacin also have good in vitro efficacy for methicillin resistant S. aureus infections. Oral 
dosing option for linezolid, chloramphenicol and rifampacin can allow earlier discharge of hospitalized patients and thus reduce 
health care expenses as well as help reduce the chances of vancomycin resistant strains emergence.
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INTRODUCTION
The  genus  Staphylococcus  includes  pathogenic 
organisms in which Staphylococcus aureus is the most 
important. It has overcome most of the therapeutic 
agents that have been developed against it in the recent 
years (1). The introduction of beta-lactamase resistant 
semi-synthetic penicillins in the early 1960’s provided 
temporary  relief  which  ended  with  the  emergence 
of  Methicillin  (oxacillin)  Resistant  Staphylococcus 
aureus (MRSA), discovered shortly after methicillin 
became available for clinical use (2).
Many  of  these  MRSA  isolates  are  becoming 
multidrug  resistant  and  are  susceptible  only  to 
glycopeptide  antibiotics  such  as  vancomycin.  Low 
level resistance even to vancomycin is emerging at 
present (1).  Prolonged hospital stays, indiscriminate 
use of antibiotics, lack of awareness, and receipt of 
antibiotics before coming to the hospital are some of 
the possible predisposing factors of MRSA emergence. 
The knowledge of MRSA prevalence and the current 
antimicrobial  profile  is  necessary  in  selection  of 
appropriate empirical treatment of these infections. 
Control of MRSA in hospitals is essential. This can 
be  achieved  by  proper  implementation  of  hospital 
infection control measures and regular surveillance 
activity. Therefore, we planned this study to determine 
the current antimicrobial profile of MRSA isolates 
from our hospital so as to formulate an appropriate as 
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MATeRIAlS AND MeTHODS
The study was conducted over a one-year (January 
2009 - December 2009) period at the  Department 
of Microbiology, Army Medical College, National 
University  of  Sciences  and Technology,  Pakistan. 
All Staphylococcus aureus isolates encountered in 
routine  clinical  specimens  received  from  clinical 
wards  of  Military  Hospital  Rawalpindi  were 
identified  morphologically  and  biochemically 
by  standard  laboratory  procedures  including  tube 
coagulase  test  and  DNase  test  using  DNase  agar 
(Oxoid Ltd, Basingstoke, Hampshire, England). MRSA 
screening was performed on Mueller-Hinton agar using 
6 μg oxacillin and 30 μg cefoxitin discs as per Clinical 
and Laboratory Standards Institute (CLSI) guidelines (3). 
Susceptibility to antimicrobial agents was determined by 
the modified Kirby Bauer disc diffusion method using 
following  antimicrobial  discs:  vancomycin  (30  μg), 
linezolid (30 μg), teicoplanin (30μg), tigecycline (30 μg), 
Fig. 1. Percentage of MRSA isolated from various specimens. 
Antibiotic  Sensitive Resistant % sensitive
Vancomycin 139 0 100
Linezolid 139 0 100
Quinopristin/Dalfopristin 139 0 100
Teicoplanin 130 9 94
Minocycline 130 9 94
Chloramphenicol 129 10 93
Tigecycline 127 12 91
Trimethoprim/sulphamethoxazole 94 45 67
Fusidic acid 91 48 65
Tetracycline 89 50 64
Rifampicin 86 53 62
Doxycycline 57 82 41
Fluoroquinolones 53 86 38
Macrolides 31 108 22
Table 1. Susceptibility pattern of MRSA against various antibiotics.
7
Chart 1: Percentage of MRSA isolated from various specimens
DISCUSSION
Fig. 1. Percentage of MRSA isolated from various specimens
58%
16%
10%
9%
7%
PUS
NBL
SPUTUM
URINE
BODY FLUIDS
PUS
NBL
SPUTUM
URINE
BODY  FLUIDS
7
Chart 1: Percentage of MRSA isolated from various specimens
DISCUSSION
Fig. 1. Percentage of MRSA isolated from various specimens
58%
16%
10%
9%
7%
PUS
NBL
SPUTUM
URINE
BODY FLUIDS
58%
7%
9%
10%
16%145 StaphylococcuS aureuS FROM PATIeNTS IN PAKISTAN
tetracycline (30 μg), minocycline (30 μg), quinopristin/
dalfopristin  (15  μg),  Fluoroquinolones  (ciprofloxacin, 
levofloxacin,  ofloxacin  and  moxifloxacin  5  μg), 
chloramphenicol (30 μg), rifampicin (5 μg), fusidic acid 
(10 μg), macrolides (erythromycin and clindamycin 15 
μg) as per CLSI guidelines (3).
ReSUlTS
A total of 139 MRSA were isolated during the study 
period. All of the isolated MRSA were found to be 
susceptible to vancomycin, linezolid and quinopristin/ 
dalfoprisitin. One hundred and thirty isolates (94%) were 
susceptible to teicoplanin and minocycline, whereas 
93% of isolates were sensitive to chloramphenicol and 
91% were sensitive to tigecycline. Only 38 and 22% 
of the isolates were susceptible to fluoroquinolones 
and  macrolides  respectively  (Table  1).  Majority  of 
MRSA were isolated from pus samples followed by 
nasobronchial lavages samples (Fig. 1).
DISCUSSION
A  study  conducted  at  the Armed  Forces  Institute 
of Pathology Rawalpindi in 2003-2004 indicated that 
there  was  no  reduced  susceptibility  of  vancomycin 
against  studied  MRSA  isolates  as  indicated  in  our 
study.  However, VISA  strains  were  detected  in  4% 
of isolates in Lahore in 2004 (4, 5). The incidence of 
VISA in the regional countries has been documented as 
3.3% (Srinagar, Kashmir, 2003), 6% (India, 2007) and 
7.5% (Iran, 2008) (6-8) . 
The results of our study are in accordance with a 
study  carried  out  at Aga  Khan  University  in  2009 
which showed variable susceptibility pattern with high 
resistance  rates  to  tetracycline  (82%),  clindamycin 
(79%), cotrimoxazole (59%), and rifampicin (50%). 
Resistance to chloramphenicol (10%) and fusidic acid 
(9%) was low (9). A study carried out at Lahore in 2009 
showed that only 4% of MRSA isolates were sensitive 
to fluoroquinoles, whereas 38% of isolates were found 
to be sensitive in our study (10).
In  our  study  100%  of  the  isolates  were  sensitive 
to linezolid which is complemented by a 2009 study 
carried out in Iran. In that study, tigecycline was also 
found to be 100% which is similar to the results of 
another study  in Iran (11).
Vancomycin and linezolid are highly effective against 
MRSA. Chloramphenicol and Minocycline also have 
good  in  vitro efficacy. Tigecycline, though effective, 
enhances health care costs enormously.
Effective  antimicrobial  activity  as  well  as  cost 
effectiveness should be considered in drugs prescribed 
for MRSA infections. Oral dosing options for linezolid 
and chloramphenicol can allow earlier discharge of 
hospitalized  patients  and  minimize  the  chances  of 
VRSA  emergence.  Good  hospital  infection  control 
measures  prove  to  be  the  main  stay  against  these 
infections because antibiotics can never be an effective 
alternative to good medical practice
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